Intercept Pharmaceuticals Inc Net Income per Employee (ICPT), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Intercept Pharmaceuticals inc   (NASDAQ: ICPT)
 

Intercept Pharmaceuticals Inc Net Income per Employee

ICPT's Quarterly Results, Trends, Rankings, Statistics
Intercept Pharmaceuticals Inc recorded a cumulative net loss of $-62 million during 12 month ending in the third quarter 2023.
The Healthcare sector has seen employees of 113 other companies achieving higher income per employee. While Intercept Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 226 to 3143.


What is Income per Employee Ratio?






ICPT Net Income per Employee (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -164,299 556,349 551,907 591,509 550,296
ICPT's Total Ranking # 3143 # 226 # 200 # 0 # 0
Seq. Net Income Change - - - - -


ICPT Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 114
Healthcare Sector # 335
Overall Market # 3143

Net Income per Employee Statistics
High Average Low
$ 591,509 $ -509,927 $ -960,979
(Dec 31 2022)   (Dec 31 2017)







Companies with similar Income per Employee for 12 month ending Sep 30 2023, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2023Number of Employees Sep 30 2023


Date modified: 2026-09-08T15:11:05+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.